Notably, vitamin K3-OH, a derivative of vitamin K3, can enhance the action of p53 in MNA-NB cells and inhibit the expression of MYCN, accompanied by a decrease in miRNA LIN28 (Yoda et al., 2019). This evidence concerns the gene TP53 and neuroblastoma.